Involvement of heparanase in tumor metastases: A new target in cancer therapy?

Journal of the National Cancer Institute

Volumn 96, Issue 16, 2004, Pages 1194-1195

  Boyd, Douglas D ^a   Nakajima, Motowo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; CATHEPSIN; COLLAGENASE; COMPLEMENTARY DNA; ENZYME INHIBITOR; GLYCOSAMINOGLYCAN POLYSULFATE; GLYCOSIDASE; HEPARAN SULFATE; HEPARANASE; HEPARANASE INHIBITOR; METALLOPROTEINASE INHIBITOR; PROTEIN KINASE B; PROTEINASE; SERINE PROTEINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANGIOGENIC FACTOR; BETA GLUCURONIDASE; GROWTH PROMOTOR; RIBOZYME;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BASEMENT MEMBRANE; CANCER; CANCER CHEMOTHERAPY; CARCINOMA CELL; EDITORIAL; ENZYME DEGRADATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; GLIOMA CELL; HUMAN; LYMPHOMA CELL; MELANOMA CELL; MEMBRANE DAMAGE; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; ADENOCARCINOMA; BREAST TUMOR; CANCER INVASION; DISEASE COURSE; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENETIC TRANSFECTION; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY;

ADENOCARCINOMA; ANGIOGENESIS INDUCING AGENTS; BASEMENT MEMBRANE; BREAST NEOPLASMS; DISEASE PROGRESSION; ENZYME INHIBITORS; FEMALE; GLUCURONIDASE; GROWTH SUBSTANCES; HEPARITIN SULFATE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, CATALYTIC; TRANSFECTION;

EID: 4344565053     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh256     Document Type: Editorial

References (10)

1. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces cell migration via protein kinase B/Akt activation. J Biol Chem 2004;279:23536-41.
2. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Rivka IM, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999;5:793-802.
3. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 1999;274:24153-60.
4. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, et al. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci U S A 2002;99:10031-6.
5. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004;96:1219-30.
6. Uno F, Fujiwara T, Taakata Y, Ohtani S, Katsuda K, Takaoka M, et al. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res 2001;61: 7855-60.
7. Kruger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, et al. Hydroxymate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res 2001;61:1272-5.
8. Holst-Hansen C, Low JA, Stephens RW, Johnson MD, Carmeliet P, Frandsen TL, et al. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat. Breast Cancer Res Treat 2001;68:225-37.
9. McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, et al. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun 2000;276:1170-7.
10. Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 1999; 18:4645-56.